Exploitation of a small molecule, potentially curative therapy for MS (Q233279): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) |
(Changed an Item) |
||||||||||||||
| Property / instance of | |||||||||||||||
| Property / instance of: Kohesio project / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / financed by | |||||||||||||||
| Property / financed by: European Union / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / financed by | |||||||||||||||
| Property / financed by: Directorate-General for Regional and Urban Policy / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / country | |||||||||||||||
| Property / country: Ireland / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / EU contribution | |||||||||||||||
63,481.87 Euro
| |||||||||||||||
| Property / EU contribution: 63,481.87 Euro / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / budget | |||||||||||||||
126,963.74 Euro
| |||||||||||||||
| Property / budget: 126,963.74 Euro / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / start time | |||||||||||||||
1 August 2015
| |||||||||||||||
| Property / start time: 1 August 2015 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / end time | |||||||||||||||
1 May 2018
| |||||||||||||||
| Property / end time: 1 May 2018 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / co-financing rate | |||||||||||||||
50.0 percent
| |||||||||||||||
| Property / co-financing rate: 50.0 percent / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / beneficiary name (string) | |||||||||||||||
Trinity College Dublin | |||||||||||||||
| Property / beneficiary name (string): Trinity College Dublin / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary | |||||||||||||||
Exploitation of a small molecule, potentially curative therapy for MS (English) | |||||||||||||||
| Property / summary: Exploitation of a small molecule, potentially curative therapy for MS (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / intervention field | |||||||||||||||
| Property / intervention field: Technology transfer and university-enterprise cooperation primarily benefiting SMEs / rank | |||||||||||||||
Normal rank | |||||||||||||||
Revision as of 13:34, 1 February 2020
Project in Ireland financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Exploitation of a small molecule, potentially curative therapy for MS |
Project in Ireland financed by DG Regio |
Statements
63,481.87 Euro
0 references
126,963.74 Euro
0 references
50.0 percent
0 references
1 August 2015
0 references
1 May 2018
0 references
Trinity College Dublin
0 references
Exploitation of a small molecule, potentially curative therapy for MS (English)
0 references
Identifiers
210
0 references